Equities

Biotricity Inc

Biotricity Inc

Actions
IndustrialsIndustrial Support Services
  • Price (USD)1.04
  • Today's Change0.02 / 1.96%
  • Shares traded64.04k
  • 1 Year change-72.92%
  • Beta1.3866
Data delayed at least 15 minutes, as of May 21 2024 16:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

  • Revenue in USD (TTM)11.63m
  • Net income in USD-15.39m
  • Incorporated2012
  • Employees55.00
  • Location
    Biotricity Inc203 Redwood Parkway, Suite 600REDWOOD CITY 94065United StatesUSA
  • Phone+1 (650) 832-1626
  • Websitehttps://www.biotricity.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fuse Medical Inc18.40m3.63m6.06m31.002.28--1.640.32950.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
Arch Therapeutics Inc130.55k-8.43m6.58m8.00------50.38-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Sonendo Inc40.19m-57.74m6.74m216.00--0.2748--0.1678-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Predictive Oncology Inc1.96m-14.78m6.93m34.00--1.69--3.54-3.66-3.660.48530.99770.10991.714.9557,642.65-82.89-91.80-108.54-126.2964.1864.64-754.19-1,419.991.35--0.0093--18.244.7545.67--5.44--
Vivos Therapeutics Inc13.36m-15.64m7.23m114.00--10.51--0.541-11.00-11.008.730.21310.9247--31.59117,219.30-108.24-89.72-243.30-149.7058.9070.20-117.06-113.15----0.00---13.8729.4843.04---8.48--
Neurometrix Inc5.27m-7.98m8.01m26.00--0.4216--1.52-6.32-6.324.209.440.23811.2510.08202,700.40-36.07-23.24-38.94-27.2661.9759.17-151.51-48.8810.11--0.00---28.52-18.18-47.84--5.03--
Nexalin Technology Inc158.86k-4.94m9.15m6.00--3.93--57.58-0.6676-0.66760.02150.31290.03630.177844.0126,476.67-112.76---139.94--82.54---3,110.58--4.75--0.00---91.62---173.80------
Citrine Global Corp0.00-2.38m9.66m18.00---------0.0025-0.00250.00-0.00280.00----0.00-173.12-298.98---964.26-------4,814.84---5.41--------41.43---5.44--
Biomerica Inc5.41m-6.35m11.11m62.00--1.42--2.06-0.3789-0.37890.32240.46420.58272.285.7487,180.80-68.45-43.55-83.73-50.3211.4115.75-117.46-55.863.37--0.00---71.71-0.8229-57.58---9.76--
Biotricity Inc11.63m-15.39m11.62m55.00------0.9997-1.75-1.751.32-2.841.922.016.55211,408.70-240.40-303.46----65.5253.00-125.43-368.780.1012-0.5855----26.00--35.36------
ALR Technologies Inc9.49k-8.00m11.76m6.00------1,238.79-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
PetVivo Holdings Inc1.05m-10.63m12.29m25.00--12.01--11.75-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
STRATA Skin Sciences Inc32.55m-11.36m13.52m99.00--1.43--0.4156-0.3248-0.32480.93070.2690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
SINTX Technologies Inc2.78m-8.88m13.85m43.00--0.581--4.99-1.95-1.950.37110.19430.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Data as of May 21 2024. Currency figures normalised to Biotricity Inc's reporting currency: US Dollar USD

Institutional shareholders

3.81%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202499.73k1.08%
Advisor Resource Council LLCas of 31 Mar 202479.07k0.85%
Geode Capital Management LLCas of 31 Mar 202464.07k0.69%
Strengthening Families & Communities LLCas of 31 Mar 202448.26k0.52%
SSgA Funds Management, Inc.as of 31 Mar 202422.55k0.24%
BlackRock Fund Advisorsas of 31 Mar 202413.38k0.14%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202412.00k0.13%
TD Waterhouse Canada, Inc.as of 31 Mar 20248.00k0.09%
Vanguard Global Advisers LLCas of 31 Mar 20242.85k0.03%
Cedar Mountain Advisors LLCas of 31 Mar 20242.50k0.03%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.